- Recruiting participants (Starts Nov. 1, 2017)
- Not accepting healthy volunteers
- UTSW Principal Investigator: Daniel C Bowers
summary
Primary: To estimate the progression-free survival (PFS) of children >= 3 years of age with WNT-driven average-risk medulloblastoma using reduced craniospinal radiotherapy (CSI) (18 Gy) with a limited target volume boost to the tumor bed of 36 Gy for a tot